BEHÇET'S SYNDROME (BS)
Clinical trials for BEHÇET'S SYNDROME (BS) explained in plain language.
Never miss a new study
Get alerted when new BEHÇET'S SYNDROME (BS) trials appear
Sign up with your email to follow new studies for BEHÇET'S SYNDROME (BS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets immune overdrive in six rare diseases
Disease control Recruiting nowThis early-stage trial is testing a drug called RAY121 in 144 people with one of six immune diseases, including antiphospholipid syndrome and bullous pemphigoid. The drug works by blocking a specific part of the immune system (the complement pathway) that can cause tissue damage.…
Matched conditions: BEHÇET'S SYNDROME (BS)
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Cheaper version of ustekinumab tested for painful Behçet's ulcers
Disease control Recruiting nowThis study is observing 208 adults with Behçet's syndrome who have painful mouth and genital ulcers that did not improve with standard treatments. Researchers are tracking how well a biosimilar (a copy) of the drug ustekinumab controls these ulcers over 24 weeks, and comparing re…
Matched conditions: BEHÇET'S SYNDROME (BS)
Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC